Titan Pharmaceuticals Inc

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Titan Pharmaceuticals Inc
CIK #0000910267
EDGAR Form CIK 2011 - 2026
10-K [0000910267]
10-Q [0000910267]
3 [0000910267]
4 [0000910267]
8-K [0000910267]
D [0000910267]
SC 13D [0000910267]
SC 13G [0000910267]
Form 13D/13G Filer Form 13D/13G Subject Filed
Sire Group Ltd Titan Pharmaceuticals Inc [2023-10-04]
Choong Choon HAU Titan Pharmaceuticals Inc [2023-07-21]
Activist Investing LLC Titan Pharmaceuticals Inc [2022-04-25]
L1 Capital Global Opportunities Master Fund Ltd Titan Pharmaceuticals Inc [2021-01-25]
Sabby Management LLC Titan Pharmaceuticals Inc [2021-01-22]
Empery Asset Management LP Titan Pharmaceuticals Inc [2021-01-21]
Intracoastal Capital LLC Titan Pharmaceuticals Inc [2020-11-09]
L1 Capital Global Opportunities Master Fund Ltd Titan Pharmaceuticals Inc [2020-10-01]
Sabby Management LLC Titan Pharmaceuticals Inc [2020-09-24]
Empery Asset Management LP Titan Pharmaceuticals Inc [2019-10-22]
Sabby Management LLC Titan Pharmaceuticals Inc [2019-08-07]
Broadfin Capital LLC Titan Pharmaceuticals Inc [2014-10-10]
Mead Robert E Titan Pharmaceuticals Inc [2014-05-21]
Braeburn Pharmaceuticals BVBA SPRL Titan Pharmaceuticals Inc [2013-12-04]
[2012-02-07]
Form 3/4/5 Subject 2011 - 2026
Ben-Tzvi Avraham
Titan Pharmaceuticals Inc
Loh Gabriel
Chay Weei Jye
Mokhtar Firdauz
Flores Garcia Francisco Osvaldo
Choong Choon Hau
Greenberg Eric Howard
Beebe Katherine
McMurdo Matthew Charles
View All
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Titan Pharmaceuticals Inc TTNP
Option to Purchase Common Stock · derivative
2025-10-01 Disposed to issuer 5,000
Titan Pharmaceuticals Inc TTNP
Option to Purchase Common Stock · derivative
2025-10-01 Disposed to issuer 1,250
Titan Pharmaceuticals Inc TTNP
Common Stock
2025-10-01 Disposed to issuer 3,313
Titan Pharmaceuticals Inc TTNP
Common Stock
2024-03-18 Conversion 54,132 $0.00
Titan Pharmaceuticals Inc TTNP
Convertible Promissory Note · derivative
2024-03-18 Conversion $0.00
Titan Pharmaceuticals Inc TTNP
Common Stock
2023-10-25 Grant 16,250 $0.00
Titan Pharmaceuticals Inc TTNP
Common Stock
2023-10-25 Grant 16,250 $0.00
Titan Pharmaceuticals Inc TTNP
Common Stock
2023-10-25 Grant 16,250 $0.00
Titan Pharmaceuticals Inc TTNP
Common Stock
2023-10-25 Grant 16,250 $0.00
Titan Pharmaceuticals Inc TTNP
Common Stock
2023-10-25 Grant 16,250 $0.00
Titan Pharmaceuticals Inc TTNP
Common Stock
2023-07-26 Grant 50,000 $0.00
Titan Pharmaceuticals Inc TTNP
Common Stock
2023-07-26 Grant 100,000 $0.00
Titan Pharmaceuticals Inc TTNP
Common Stock
2023-07-26 Grant 50,000 $0.00
Titan Pharmaceuticals Inc TTNP
Common Stock
2023-07-26 Grant 50,000 $0.00
Titan Pharmaceuticals Inc TTNP
Common Stock
2023-07-26 Grant 50,000 $0.00
Titan Pharmaceuticals Inc TTNP
Common Stock
2023-07-26 Grant 50,000 $0.00
Titan Pharmaceuticals Inc TTNP
Common Stock
2023-07-26 Grant 50,000 $0.00
Titan Pharmaceuticals Inc TTNP
Option to Purchase Common Stock · derivative
2023-06-29 Grant 100,000 $0.00
Titan Pharmaceuticals Inc TTNP
Option to Purchase Common Stock · derivative
2023-06-29 Grant 25,000 $0.00
Titan Pharmaceuticals Inc TTNP
Option to Purchase Common Stock · derivative
2023-06-29 Grant 25,000 $0.00
showing 20 of 131 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com